Survivors of Childhood ALL May Have Higher Risk of Delayed Neurodevelopment

Cognitive performance is impaired in childhood survivors diagnosed with acute lymphoblastic leukemia (ALL) and received increased chemotherapy, finds a new study.

New research gives unique insights into the mechanism of how childhood acute lymphoblastic leukemia (ALL) and chemotherapy affect brain function. The findings of the study are published in the journal Brain Connectivity.

The findings from comparative studies of structural and functional connectome organization, showing that connectome disruption is associated with delayed neurodevelopment.

Acute Lymphoblastic Leukemia - Incidence Causes Symptoms Diagnosis Treatment Prognosis
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood cancers and can be fatal in weeks if left untreated.

‘Cancer survivors who are diagnosed with ALL at a younger age and received increased chemotherapy is associated with a higher risk of delayed neurodevelopment.’

In the article entitled "Brain Network Connectivity and Executive Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia," Kevin Krull, PhD, St. Jude Children's Research Hospital, Memphis, TN and a team of researchers from St. Jude's and University of Texas MD Anderson Cancer Center, Houston reported poor global connectivity and lower information exchange and network integration in study participants with executive dysfunction compared to those without which is one of the most consistently observed deficits observed in this population.

The study included 161 long-term survivors of ALL who were 8-21 years of age.

The younger the age at which the children had been diagnosed with ALL and the more chemotherapy they had received correlated with increased risk for impaired connectome efficiency and poorer global information processing.

Blood Cancer Treatment Outcome Depends on Genetic Make Up of Proteins
The genetic make-up can impact the activity of the immune system and the body's ability to fight cancer.

"The 10-year cure rate for ALL is approaching over 90% in children," states Christopher Pawela, Ph.D., Co-Editor-in-Chief, Brain Connectivity.

"Long-term cognitive impairment is a serious issue facing ALL survivors, and there has been a lack of understanding of the mechanism of how ALL and chemotherapy affect brain function. Dr. Krull and his colleagues have designed a very large follow-up study of ALL survivors investigating brain functional changes after a cure is obtained. They establish for the first time using brain imaging that age of diagnosis and the length of chemotherapeutic treatment have compounding maladaptive effects on the brain networks involved in executive cognitive function."

Combination Drug Therapy - A new strategy For Brain and Blood Cancers
Brain and Blood cancers can be treated by using drug combination as a new strategy, reveals study.

Source-Eurekalert

Vitamin C May Encourage Blood Cancer Stem Cells To Die
Vitamin C activates demethylation of TET2 enzyme, which signals stem cells to mature and die.